Matches in Nanopublications for { ?s ?p "[Platelet-derived growth factor-BB (PDGF-BB) enhances the invasive activity of malignant peripheral nerve sheath tumor (MPNST) cells through platelet-derived growth factor receptor (PDGFR) phosphorylation, whereas imatinib mesylate inhibited such activity, suggesting that targeting PDGFR-beta may result in the establishment of novel treatment for MPNST.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP479618.RAmIfotByLAsaFmQEsPKL2uJOcrE1H77p27-78WvQ3J9c130_assertion description "[Platelet-derived growth factor-BB (PDGF-BB) enhances the invasive activity of malignant peripheral nerve sheath tumor (MPNST) cells through platelet-derived growth factor receptor (PDGFR) phosphorylation, whereas imatinib mesylate inhibited such activity, suggesting that targeting PDGFR-beta may result in the establishment of novel treatment for MPNST.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479618.RAmIfotByLAsaFmQEsPKL2uJOcrE1H77p27-78WvQ3J9c130_provenance.
- NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_assertion description "[Platelet-derived growth factor-BB (PDGF-BB) enhances the invasive activity of malignant peripheral nerve sheath tumor (MPNST) cells through platelet-derived growth factor receptor (PDGFR) phosphorylation, whereas imatinib mesylate inhibited such activity, suggesting that targeting PDGFR-beta may result in the establishment of novel treatment for MPNST.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- NP753146.RAkQ-4Edf0gYH4uSvIU5j6al1SrHVoOmOfYsHo_z-U7G4130_assertion description "[Platelet-derived growth factor-BB (PDGF-BB) enhances the invasive activity of malignant peripheral nerve sheath tumor (MPNST) cells through platelet-derived growth factor receptor (PDGFR) phosphorylation, whereas imatinib mesylate inhibited such activity, suggesting that targeting PDGFR-beta may result in the establishment of novel treatment for MPNST.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753146.RAkQ-4Edf0gYH4uSvIU5j6al1SrHVoOmOfYsHo_z-U7G4130_provenance.